Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
635.35B
Market cap635.35B
Price-Earnings ratio
39.10
Price-Earnings ratio39.10
Dividend yield
2.05%
Dividend yield2.05%
Average volume
8.30M
Average volume8.30M
High today
$264.12
High today$264.12
Low today
$259.04
Low today$259.04
Open price
$261.25
Open price$261.25
Volume
1.39M
Volume1.39M
52 Week high
$281.07
52 Week high$281.07
52 Week low
$184.66
52 Week low$184.66

Stock Snapshot

With a market cap of 635.35B, Johnson & Johnson(JNJ) trades at $263.64. The stock has a price-to-earnings ratio of 39.10 and currently yields dividends of 2.05%.

As of 2026-10-22, Johnson & Johnson(JNJ) stock has fluctuated between $259.04 and $264.12. The current price stands at $263.64, placing the stock +1.8% above today's low and -0.2% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 1.39M, compared to an average daily volume of 8.3M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

JNJ News

New York Times 2h
J.J. Watt gets permanent role as top NFL game analyst with CBS Sports - The New York Times

...

J.J. Watt gets permanent role as top NFL game analyst with CBS Sports - The New York Times
24/7 Wall St. 2h
JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up

Johnson and Johnson just posted a quarter where one business charged ahead while another quietly stalled, and which side wins out will determine whether the sto...

JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up
24/7 Wall St. 2h
Social Security Isn't Enough: 5 Secure Dividend Stocks to Fund Your Retirement

Investing Social Security Isn’t Enough: 5 Secure Dividend Stocks to Fund Your Retirement A 3.3% Social Security bump leaves most retirees short, but five blue-c...

Social Security Isn't Enough: 5 Secure Dividend Stocks to Fund Your Retirement

Analyst ratings

70%

of 27 ratings
Buy
70.4%
Hold
22.2%
Sell
7.4%

More JNJ News

TipRanks 3h
Johnson & Johnson reports real-world VARIPULSE Pro platform data

Johnson & Johnson announced new data from the late-breaking VARIPURE and Omny-IRE studies presented at the Asia Pacific Heart Rhythm Society 2026 Annual Meeting...

Simply Wall St 4h
Johnson & Johnson Launched A Coronary Catheter That Halves Treatment Time

Johnson & Johnson (NYSE:JNJ) has introduced its Shockwave C2 Aero Fly Coronary IVL Catheter in the U.S. coronary care market. The next-generation device is des...

Johnson & Johnson Launched A Coronary Catheter That Halves Treatment Time
The Motley Fool 16h
Vanguard Health Care ETF vs iShares U.S. Healthcare ETF

Vanguard Health Care ETF (VHT -0.41%) and iShares U.S. Healthcare ETF (IYH -0.40%) provide similar exposure, but the Vanguard fund offers significantly higher d...

Vanguard Health Care ETF vs iShares U.S. Healthcare ETF
24/7 Wall St. 20h
Johnson & Johnson Raised Its Dividend Every Year. Why Did It Trail the S&P 500?

Investing Johnson & Johnson Raised Its Dividend Every Year. Why Did It Trail the S&P 500? Johnson and Johnson has raised its dividend every single year for 64 y...

Johnson & Johnson Raised Its Dividend Every Year. Why Did It Trail the S&P 500?
TipRanks 1d
Johnson & Johnson downgraded to Hold from Buy at Erste Group

Erste Group downgraded Johnson & Johnson to Hold from Buy. On a sector-by-sector basis, the stock is trading at a high valuation, which leads the firm to believ...

The Wall Street Journal 1d
Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market

Johnson & Johnson is forecasting double-digit sales growth by the end of the decade. Jeff Schear / Johnson & Johnson / Getty Images Healthcare stocks no longer...

Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market
TipRanks 2d
Johnson & Johnson: Buy Rating Reiterated on Underappreciated Pharma and MedTech Growth, $300 Price Target Unchanged

Analyst Michael Nedelcovych from TD Cowen maintained a Buy rating on Johnson & Johnson and keeping the price target at $300.00. Michael Nedelcovych has given hi...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.